NORML

MAY 31, 2019

Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis. Click here to email your governor in support of medical cannabis access. Legislation is pending, Senate Bill 1286, to expand patient access to medical cannabis in Arizona.

Legislation 109

Legislation Access Banking Hemp 109

NORML

MARCH 22, 2019

Senate Bill 34 would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Legislation is pending, Senate Bill 59, to expand medical cannabis access. CA resident? DE resident? HI resident? HI resident?

Legislation 133

Legislation Hemp Patients Compliance 133

Cannabis Law Report

MARCH 3, 2022

Data from this report will help OPS better prepare for license and compliance work in January 2023 when it starts accepting license applications for the program. Who is interested in accessing psilocybin services and why? The survey’s results show strong interest in the psilocybin program, particularly in accessing services.

Programs 52

Programs Access Data Legislation 52

Cannabis Law Report

MAY 31, 2022

The only opportunity to currently participate would be through an active clinical trial or via an argument under the Right to Try Act of 2018 (an act which provides a pathway for patients with life-threatening diseases or conditions to access unapproved treatments). Emerging Non-Medical State-Regulated Path. Underground Therapists.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

SEPTEMBER 16, 2022

The law authorizes doctors to prescribe cannabis for a long list of specific qualifying conditions, as well as any condition the doctor “considers debilitating to an individual patient” that the doctor “is qualified through [their] medical education and training to treat.” Code § 16-12-191. Code §§ 20-2A-1. North Carolina.

Law 52

Law Programs Cultivation Dispensary 52

Cannabis Law Report

MAY 29, 2022

9] Experts predict that this therapy could receive full FDA approval as soon as 2023. [10] Schedule I controlled substances are the most restricted in terms of research, supply, and access, [13] and possession is criminalized. Fast Track review is for drugs that treat serious conditions and fill an unmet medical need.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 28, 2021

Merger includes retail, distribution and cultivation capabilities in the limited license market where adult-use sales are expected to reach up to US$230 million in 2023[1]. Adds expertise to support best manufacturing practices, innovation and regulatory compliance. Toronto, Ontario–(Newsfile Corp.

Retail 59

Retail Dispensary Packaging History 59

Cannabis Law Report

NOVEMBER 8, 2021

1 The transaction is expected to close in the second half of 2022, subject to customary approvals and conditions. An incremental earnout of up to 1 million Curaleaf Shares may be paid in 2023 based on the business exceeding certain EBITDA targets for the year 2022. Transaction Advisors.

Retail 52

Retail Dispensary Vaping Topical 52

Canna Law Blog

JANUARY 25, 2023

We expect 2023 will see even more progress as we push towards New York having a fully functioning cannabis industry. Let’s take a look at the noteworthy developments of 2022 and what we expect to see in 2023. New York issued (conditional) adult-use cannabis licenses A legal adult-use cannabis industry requires licenses to be issued.

Dispensary 71

Dispensary Conditions Cultivation Retail 71

Cannabis Law Report

DECEMBER 8, 2021

It emerges from the 2018-2023 coalition agreement that legislation on recreational cannabis will be drafted ( 2018-2023 Coalition Agreement ) . Growing all four plants outdoors has the advantage that, due to climatic conditions in Luxembourg, the THC level is generally lower than the THC level of plants grown indoors.

Recreational 52

Recreational Seed-To-Sale Consumption Events 52

Cannabis Law Report

AUGUST 4, 2021

from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Objectives for FY 2023 also remain unchanged and do not include any COVID-19 impact either.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

FEBRUARY 16, 2022

Final approval for listing of the Jones Shares on the CSE will be subject to Jones fulfilling certain standard conditions of the CSE set out in its conditional acceptance letter. Securities Act and all applicable state securities laws or compliance with the requirements of an applicable exemption therefrom.

Events 52

Events Conditions Edibles Business 52

Cannabis Law Report

JUNE 11, 2022

As the Company’s president and chairman of the board of directors, he has been responsible for the Company’s Ontario Securities Commission and Canadian Securities Exchange compliance, investor relations, financing, and corporate development. In the last five years he has successfully raised over $12M for his startups.

Pharmaceutical 52

Pharmaceutical Media Access Business 52

NORML

APRIL 5, 2019

She also signed bills to allow medical cannabis to be administered to patients while at school, and a broader medical expansion bill that adds several new qualifying conditions and patient protections. Governor Jared Polis (D) of Colorado signed legislation into law to add autism as a medical cannabis qualifying condition. CA resident?

Legislation 184

Legislation Banking Hemp Compliance 184

NORML

MARCH 29, 2019

Governor Gary Herbert (R) of Utah signed legislation into law that strengthens protections for medical cannabis patients and further improves upon the state’s new medical cannabis access program. Legislation is pending, Senate Bill 59, to expand medical cannabis access. CA resident? DE resident? HI resident? HI resident?

Legislation 162

Legislation Decriminalization Hemp Patients 162

Cannabis Law Report

JUNE 1, 2021

Implementation of supply chain optimization well underway with network optimization and complexity reduction initiatives expected to realize our previously stated cost savings of $150 million to $200 million by the end of the first half of FY 2023. A replay will be accessible by webcast until 11:59 PM ET on August 30, 2021 at: [link].

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

NOVEMBER 17, 2021

Additionally, NuLeaf owns a third licensed retail dispensary located directly on Las Vegas Boulevard (the “Las Vegas Strip Dispensary”), expected to become operational in early 2022, subject to regulatory approval and other conditions. 1 Includes an awarded conditional dispensary where Jushi owns 49%. or greater than $7.00

Dispensary 52

Dispensary Wellness and Beauty Retail Cultivation 52

Cannabis Law Report

AUGUST 6, 2021

“We’re continuing to drive cost savings and operational efficiencies across the company, and remain broadly on track to our target of $150 – $200 million in fiscal 2022- fiscal 2023,” added Mike Lee , CFO. “We A replay will be accessible by webcast until 11:59 PM ET on November 4, 2021 at: [link]. Webcast Information.

Vaping 105

Vaping Research and Development Data Business 105

SpeedWeed

APRIL 22, 2021

“It has been scientifically proven that medical marijuana has a considerable impact in treating conditions common with veterans when they return from service, like chronic pain and PTSD,” said Rep. To fund the research and policy changes, the bill would allocate $15 million in federal funding from the 2022 and 2023 fiscal budgets.

Chronic Pain 52

Chronic Pain Legalization Treatment Conditions 52

Meadow

DECEMBER 24, 2017

One part of the Type 9 creation that’s important is it’s exempt from the public access provisions. So the concern about having limited access areas, or areas that are only open to employees versus the general public, with Type 9 there’s less of that concern because you’re not open to the general public.

Packaging 40

Packaging Retail Edibles Wellness and Beauty 40

Cannabis Law Report

JANUARY 7, 2022

Their research focuses on medical conditions such as the treatment of neuropathies, autism, opioid dependence, and sickle cell disease. Dispensaries were declared essential businesses and patients were given access to telemedicine consultations to obtain medical marijuana user cards. Effects of COVID-19 on the cannabis space.

Programs 52

Programs Marijuana Dispensary Banking 52